Teva Pharmaceutical Industries Ltd (TEVA)
13.98
-0.10
(-0.71%)
USD |
NYSE |
May 03, 16:00
14.04
+0.06
(+0.43%)
Pre-Market: 20:00
Teva Pharmaceutical Industries Market Cap: 15.67B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 03, 2024 | 15.67B |
May 02, 2024 | 15.79B |
May 01, 2024 | 15.67B |
April 30, 2024 | 15.75B |
April 29, 2024 | 15.81B |
April 26, 2024 | 15.48B |
April 25, 2024 | 14.85B |
April 24, 2024 | 14.59B |
April 23, 2024 | 14.59B |
April 22, 2024 | 14.44B |
April 19, 2024 | 14.42B |
April 18, 2024 | 14.33B |
April 17, 2024 | 14.78B |
April 16, 2024 | 14.68B |
April 15, 2024 | 14.83B |
April 12, 2024 | 14.91B |
April 11, 2024 | 15.55B |
April 10, 2024 | 15.53B |
April 09, 2024 | 15.66B |
April 08, 2024 | 15.92B |
April 05, 2024 | 15.98B |
April 04, 2024 | 15.62B |
April 03, 2024 | 15.83B |
April 02, 2024 | 15.54B |
April 01, 2024 | 15.59B |
Date | Value |
---|---|
March 28, 2024 | 15.82B |
March 27, 2024 | 16.18B |
March 26, 2024 | 15.85B |
March 25, 2024 | 15.76B |
March 22, 2024 | 15.57B |
March 21, 2024 | 15.42B |
March 20, 2024 | 15.11B |
March 19, 2024 | 14.97B |
March 18, 2024 | 14.93B |
March 15, 2024 | 15.06B |
March 14, 2024 | 15.13B |
March 13, 2024 | 15.30B |
March 12, 2024 | 15.12B |
March 11, 2024 | 14.97B |
March 08, 2024 | 15.27B |
March 07, 2024 | 15.37B |
March 06, 2024 | 15.17B |
March 05, 2024 | 15.18B |
March 04, 2024 | 15.07B |
March 01, 2024 | 15.13B |
February 29, 2024 | 14.74B |
February 28, 2024 | 14.68B |
February 27, 2024 | 14.91B |
February 26, 2024 | 14.90B |
February 23, 2024 | 14.45B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
6.726B
Minimum
Aug 15 2019
16.27B
Maximum
May 06 2019
10.72B
Average
10.44B
Median
Dec 11 2019
Market Cap Benchmarks
Viatris Inc | 13.99B |
Alvotech | 4.026B |
AstraZeneca PLC | 236.72B |
Corcept Therapeutics Inc | 2.538B |
GSK PLC | 88.70B |
Market Cap Related Metrics
PS Ratio | 0.9901 |
Price to Book Value | 2.088 |
Price to Free Cash Flow | 18.63 |
Price | 13.98 |
Earnings Yield | -3.36% |
Operating PE Ratio | 4.915 |
Normalized PE Ratio | 8.657 |